Supernus Pharmaceuticals
SUPN
$27.11
Share price
0.59%
Change (1 day)
-10.20%
Change (1 year)
Categories
Market capitalization of Supernus Pharmaceuticals (SUPN)
Market cap: $1.44 Billion
As of May 2022 Supernus Pharmaceuticals has a market cap of $1.44 Billion. This makes Supernus Pharmaceuticals the world's 3923th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Supernus Pharmaceuticals from 2012 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $1.43 B | -7.74% |
| 2021 | $1.55 B | 16.58% |
| 2020 | $1.33 B | 6.75% |
| 2019 | $1.24 B | -28.3% |
| 2018 | $1.73 B | -14.92% |
| 2017 | $2.04 B | 63.31% |
| 2016 | $1.25 B | 89.92% |
| 2015 | $0.65 B | 84.65% |
| 2014 | $0.35 B | 18.31% |
| 2013 | $0.30 B | 37.31% |
| 2012 | $0.21 B |
End of Day market cap according to different sources
On May 19th, 2022 the market cap of Supernus Pharmaceuticals was reported to be:
$1.44 Billion
$1.44 Billion
$1.44 Billion
$1.44 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $457.70 B | 31,508.82% | 🇺🇸 USA |
 Abbott Laboratories ABT | $196.87 B | 13,496.09% | 🇺🇸 USA |
 Eli Lilly LLY | $272.00 B | 18,684.27% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $161.72 B | 11,068.50% | 🇺🇸 USA |
 Zogenix ZGNX | $1.50 B | 3.60% | 🇺🇸 USA |
 United Therapeutics UTHR | $8.43 B | 482.84% | 🇺🇸 USA |